CRYSTALLINE SOLVATES AND COMPLEXES OF (1S)-1,5-ANHYDRO-1-C-(3-((PHENYL)METHYL)PHENYL)-D-GLUCITOL DERIVATIVES WITH AMINO ACIDS AS SGLT2 INHIBITORS FOR TREATMENT OF DIABETES
PROBLEM TO BE SOLVED: To provide free acid polymorphic crystal structures of SGLT2 inhibitors, pharmaceutical compositions thereof, process for preparing such crystal structures, and methods of treating disorders, such as diabetes, therewith.SOLUTION: The present invention relates to physical crystal structures of a compound of the following formula, especially pharmaceutical compositions containing the following compound, processes for preparing the same, intermediates used in preparing the same, and methods of treating diseases such as diabetes using such structures.【課題】SGLT2阻害剤の遊離酸多形結晶構造、その医薬組成物、この様な結晶構造の製造方法、およびそれと共に糖尿病のような傷害の治療方法に関する。【解決手段】下記式の化合物の物理的な結晶構造物、特に下記の化合物を含む医薬組成物、その製造方法、その製造に用いられる中間体、並びにこのような構造を用いた糖尿病のような疾患の治療方法。【選択図】なし